Santero Therapeutics is a start-up biotech active in the field of antibiotics discovery. We are developing first-in-class, novel generations of drugs to fight multiple resistant pathogens
Total raised: $8.57M
Founded date: 2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.06.2023 | Series A | $8.57M | Newton Bio... |
Mentions in press and media 2
| Date | Title | Description |
| 08.06.2023 | Santero Raises €8M in Series A Funding | Santero, a Charleroi, Belgium-based company which is dedicated to the development of antibiotics against multi-drug resistant infections, raised €8M in Series A funding. The round was led by Newton Biocapital, joined by SFPIM, WE Life Scien... |
| - | Santero Therapeutics | “Santero Therapeutics” |